Trypanosomiasis American
Mostrando 1-12 de 43 artigos, teses e dissertações.
-
1. Ergosterol isolated from the basidiomycete Pleurotus salmoneostramineus affects Trypanosoma cruzi plasma membrane and mitochondria
Abstract Background Major drawbacks of the available treatment against Chagas disease (American trypanosomiasis) include its toxicity and therapeutic inefficiency in the chronic phase of the infection, which makes it a concern among neglected diseases. Therefore, the discovery of alternative drugs for treating chronic Chagas disease requires immediate acti
J. Venom. Anim. Toxins incl. Trop. Dis. Publicado em: 06/07/2017
-
2. Sexual transmission of American trypanosomiasis in humans: a new potential pandemic route for Chagas parasites
BACKGROUND The Trypanosoma cruzi infection endemic in Latin America has now spread to several countries across four continents; this endemic involves triatomine vector-free protists. We hypothesised that the sexual transmission of T. cruzi contributes to the ongoing spread of Chagas disease. OBJECTIVES A short-term longitudinal study was conducted to eva
Mem. Inst. Oswaldo Cruz. Publicado em: 2017-06
-
3. PREVALENCE OF AMERICAN TRYPANOSOMIASIS AND LEISHMANIASES IN DOMESTIC DOGS IN A RURAL AREA OF THE MUNICIPALITY OF SÃO JOÃO DO PIAUÍ, PIAUÍ STATE, BRAZIL
SUMMARY Chagas disease and the leishmaniases are endemic zoonoses of great importance to public health in the state of Piauí, Brazil. The domestic dog (Canis familiaris) is a major reservoir, host of Trypanosoma cruzi and Leishmania spp. in both urban and rural areas, playing an important role in the transmission of these parasites. The present study evalua
Rev. Inst. Med. trop. S. Paulo. Publicado em: 03/11/2016
-
4. Heterochromatin base pair composition and diversification in holocentric chromosomes of kissing bugs (Hemiptera, Reduviidae)
The subfamily Triatominae (Hemiptera, Reduviidae) includes 150 species of blood-sucking insects, vectors of Chagas disease or American trypanosomiasis. Karyotypic information reveals a striking stability in the number of autosomes. However, this group shows substantial variability in genome size, the amount and distribution of C-heterochromatin, and the chro
Mem. Inst. Oswaldo Cruz. Publicado em: 2016-10
-
5. The potential influence of atherogenic dyslipidemia on the severity of chronic Chagas heart disease
SUMMARY Introduction: chronic Chagas heart disease (CCHD) is the most common manifestation of American Trypanosomiasis, causing about 50,000 deaths annually. Several factors bear correlation with the severity of CCHD. However, to our knowledge, the assessment on the contribution of major cardiovascular risk factors (CRF), such as hypertension and atherogeni
Rev. Assoc. Med. Bras.. Publicado em: 2016-02
-
6. American trypanosomiasis and associated risk factors in owned dogs from the major city of Yucatan, Mexico
AbstractBackground The American trypanosomiasis is a zoonosis caused by the protozoaTrypanosoma cruzi (T. cruzi). The disease is widely distributed throughout the American continent, affecting a wide range of hosts, including dogs. It is present in the canine population in the State of Yucatan, Mexico. However, no significant studies in owned dogs have been
J. Venom. Anim. Toxins incl. Trop. Dis. Publicado em: 20/10/2015
-
7. Long-term follow-up of a patient since the acute phase of Chagas disease (South American trypanosomiasis): further treatment and cure of the infection
ABSTRACTA woman had been followed since 1957 for acute phase Chagas disease. Parasitological and serological tests were positive, and treatment included benznidazole in 1974. Following treatment, parasitological test results were negative and conventional serology remained positive until 1994, with subsequent discordant results (1995-1997). The results becam
Rev. Soc. Bras. Med. Trop.. Publicado em: 2015-10
-
8. Integrated control of Chagas disease for its elimination as public health problem - A Review
Chagas disease or American trypanosomiasis is, together with geohelminths, the neglected disease that causes more loss of years of healthy life due to disability in Latin America. Chagas disease, as determined by the factors and determinants, shows that different contexts require different actions, preventing new cases or reducing the burden of disease. Cont
Mem. Inst. Oswaldo Cruz. Publicado em: 2015-05
-
9. Interruption of vector transmission by native vectors and “the art of the possible”
In a recent article in the Reader’s Opinion, advantages and disadvantages of the certification processes of interrupted Chagas disease transmission (American trypanosomiasis) by native vector were discussed. Such concept, accepted by those authors for the case of endemic situations with introduced vectors, has been built on a long and laborious process by
Mem. Inst. Oswaldo Cruz. Publicado em: 2014-02
-
10. Challenges and perspectives of Chagas disease: a review
Chagas disease (CD), also known as American trypanosomiasis, is caused by the flagellated protozoan Trypanosoma cruzi, and affects an estimated 8 to 10 million people worldwide. In Latin America, 25 million people live in risk areas, while in 2008 alone, 10,000 CD-related deaths were reported. This review aimed to evaluate the challenges of CD control, futur
J. Venom. Anim. Toxins incl. Trop. Dis. Publicado em: 19/12/2013
-
11. Avaliação do teste da caminhada de seis minutos em pacientes com cardiomiopatia da doença de Chagas e com hipertensão arterial sistêmica.
Pacientes com insuficiência cardíaca crônica devido à doença de Chagas e Hipertensão Arterial Sistêmica (Chagas-HAS) não apresentam dados que avaliem sua capacidade física com o teste da caminhada de 6 minutos (TC6). Casuística e Método: Um total de 140 pacientes seguidos rotineiramente no Ambulatório de Cardiomiopatia do serviço do Hospital de
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 20/11/2009
-
12. Elimination of Chagas disease transmission: perspectives
One hundred years after its discovery by Carlos Chagas, American trypanosomiasis, or Chagas disease, remains an epidemiologic challenge. Neither a vaccine nor an ideal specific treatment is available for most chronic cases. Therefore, the current strategy for countering Chagas disease consists of preventive actions against the vector and transfusion-transmit
Memórias do Instituto Oswaldo Cruz. Publicado em: 2009-07